Table 2:
Patient characteristics and outcomes of the 5 outflow graft obstruction patients
| Patient | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Age [years]a | 25 | 77 | 61 | 71 | 58 |
| Sex | Male | Male | Male | Male | Male |
| Aethiology | DCM | DCM | DCM | DCM | DCM |
| Indication | BTT | DT | BTT | DT | BTT |
| INTERMACS | 1 | 4 | 3 | 3 | 1 |
| HeartMate | II | II | 3 | 3 | 3 |
| OGO | |||||
| Onset [day] | 1184 | 1506 | 462 | 1043 | 412 |
| Degree | 60% | 85% | 50% | 20% | 65% |
| Location | Close to the pump | Full-length beneath BR | Full-length beneath BR | Close to the pump | Close to the pump |
| Therapy | Reoperation | Reoperation | None | None | None |
| Symptoms | Haemolysis | None | None | None | None |
| Outcome | Death (pod 36) | Ongoing (2864 daysb) | Ongoing (2206 daysb) | Ongoing (2052 daysb) | Ongoing (1767 daysb) |
a
Age at time of LVAD implantation.
b
Since implantation.
BR: bend relief; BTT: bridge to transplantation; DCM: dilatative cardiomyopathy; DT: destination therapy; ICM: ischaemic cardiomyopathy; INTERMACS: Interagency Registry for Mechanically Assisted Circulatory Support; OGO: outflow graft obstruction; pod: postoperative day.